# PRD: BIOMAX AI v2.0

**Version:** 1.0  
**Last Updated:** 2026-01-26  
**Author:** Product Agent  
**Status:** Draft

---

## Executive Summary

BIOMAX AI v2.0 ‚Äî —ç—Ç–æ –º—É–ª—å—Ç–∏–∞–≥–µ–Ω—Ç–Ω–∞—è AI-–ø–ª–∞—Ç—Ñ–æ—Ä–º–∞ –¥–ª—è —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è –∑–¥–æ—Ä–æ–≤—å–µ–º –∏ –±–∏–æ—Ö–∞–∫–∏–Ω–≥–∞, –ø–æ–∑–∏—Ü–∏–æ–Ω–∏—Ä—É–µ–º–∞—è –∫–∞–∫ "Personal Health Operating System". –ü—Ä–æ–¥—É–∫—Ç –æ–±—ä–µ–¥–∏–Ω—è–µ—Ç 15 —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö AI-–∞–≥–µ–Ω—Ç–æ–≤, 100+ –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏–π —Å —É—Å—Ç—Ä–æ–π—Å—Ç–≤–∞–º–∏ –∏ —Å–µ—Ä–≤–∏—Å–∞–º–∏, –∏ —É–Ω–∏–∫–∞–ª—å–Ω—É—é —Å–∏—Å—Ç–µ–º—É Custom RAG –¥–ª—è —Å–æ–∑–¥–∞–Ω–∏—è –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –±–∞–∑—ã –∑–Ω–∞–Ω–∏–π. –ü–ª–∞—Ç—Ñ–æ—Ä–º–∞ –Ω–∞—Ü–µ–ª–µ–Ω–∞ –Ω–∞ –ø—Ä–æ–¥–≤–∏–Ω—É—Ç—ã—Ö –±–∏–æ—Ö–∞–∫–µ—Ä–æ–≤, health optimizers –∏ –ª—é–¥–µ–π, —Ñ–æ–∫—É—Å–∏—Ä—É—é—â–∏—Ö—Å—è –Ω–∞ –¥–æ–ª–≥–æ–ª–µ—Ç–∏–∏, –≤ –ø–µ—Ä–≤—É—é –æ—á–µ—Ä–µ–¥—å –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä—ã–Ω–∫–µ.

**–ö–ª—é—á–µ–≤—ã–µ –¥–∏—Ñ—Ñ–µ—Ä–µ–Ω—Ü–∏–∞—Ç–æ—Ä—ã:**
- –ú—É–ª—å—Ç–∏–∞–≥–µ–Ω—Ç–Ω–∞—è AI-–∞—Ä—Ö–∏—Ç–µ–∫—Ç—É—Ä–∞ (15 —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –∞–≥–µ–Ω—Ç–æ–≤)
- Custom RAG ‚Äî –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–∏ —Å–æ–∑–¥–∞—é—Ç —Å–≤–æ—é –±–∞–∑—É –∑–Ω–∞–Ω–∏–π —Å –ø—Ä–æ—Ç–æ–∫–æ–ª–∞–º–∏
- N=1 Biohacker Lab –¥–ª—è –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –ø–µ—Ä—Å–æ–Ω–∞–ª—å–Ω—ã—Ö —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–æ–≤
- –ü–æ–ª–Ω—ã–π –æ—Ö–≤–∞—Ç –≤—Å–µ—Ö –∫–∞—Ç–µ–≥–æ—Ä–∏–π –±–∏–æ—Ö–∞–∫–∏–Ω–≥–∞ –≤ –æ–¥–Ω–æ–π –ø–ª–∞—Ç—Ñ–æ—Ä–º–µ
- –†–æ—Å—Å–∏–π—Å–∫–∞—è –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏—è –∏ 152-–§–ó compliance

---

## Problem Statement

### Current State

–°—É—â–µ—Å—Ç–≤—É—é—â–∏–µ —Ä–µ—à–µ–Ω–∏—è –Ω–∞ —Ä—ã–Ω–∫–µ health optimization –∏ –±–∏–æ—Ö–∞–∫–∏–Ω–≥–∞ –∏–º–µ—é—Ç —Ñ—É–Ω–¥–∞–º–µ–Ω—Ç–∞–ª—å–Ω—ã–µ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è:

| –ü—Ä–æ–±–ª–µ–º–∞ | –¢–µ–∫—É—â–µ–µ —Å–æ—Å—Ç–æ—è–Ω–∏–µ | –í–ª–∏—è–Ω–∏–µ –Ω–∞ –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª—è |
|----------|-------------------|-------------------------|
| **–§—Ä–∞–≥–º–µ–Ω—Ç–∞—Ü–∏—è –¥–∞–Ω–Ω—ã—Ö** | –î–∞–Ω–Ω—ã–µ —Ä–∞–∑–±—Ä–æ—Å–∞–Ω—ã –ø–æ 5-10+ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è–º (Oura, MyFitnessPal, CGM app, Apple Health, etc.) | –ü–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª—å —Ç—Ä–∞—Ç–∏—Ç 5+ —á–∞—Å–æ–≤/–Ω–µ–¥–µ–ª—é –Ω–∞ —Ä—É—á–Ω—É—é –∞–≥—Ä–µ–≥–∞—Ü–∏—é –¥–∞–Ω–Ω—ã—Ö –≤ Excel |
| **–£–∑–∫–∏–π —Ñ–æ–∫—É—Å —Ä–µ—à–µ–Ω–∏–π** | InsideTracker (—Ç–æ–ª—å–∫–æ blood), Levels (—Ç–æ–ª—å–∫–æ CGM), Oura (—Ç–æ–ª—å–∫–æ sleep/HRV) | –ù–µ—Ç –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –≤–∏–¥–µ—Ç—å —Ü–µ–ª–æ—Å—Ç–Ω—É—é –∫–∞—Ä—Ç–∏–Ω—É –∑–¥–æ—Ä–æ–≤—å—è |
| **–û—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∞—Ü–∏–∏** | –†–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –Ω–µ —É—á–∏—Ç—ã–≤–∞—é—Ç –≥–µ–Ω–µ—Ç–∏–∫—É, –∏—Å—Ç–æ—Ä–∏—é, –∫–æ–Ω—Ç–µ–∫—Å—Ç –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª—è | "–û–¥–Ω–∞ —Ç–∞–±–ª–µ—Ç–∫–∞ –¥–ª—è –≤—Å–µ—Ö" –Ω–µ —Ä–∞–±–æ—Ç–∞–µ—Ç –¥–ª—è –±–∏–æ—Ö–∞–∫–∏–Ω–≥–∞ |
| **–ó–∞–∫—Ä—ã—Ç—ã–µ —ç–∫–æ—Å–∏—Å—Ç–µ–º—ã** | –ù–µ–ª—å–∑—è –∑–∞–≥—Ä—É–∑–∏—Ç—å —Å–≤–æ–∏ –ø—Ä–æ—Ç–æ–∫–æ–ª—ã –∏–ª–∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è | –ü—Ä–æ–¥–≤–∏–Ω—É—Ç—ã–µ –±–∏–æ—Ö–∞–∫–µ—Ä—ã –Ω–µ –º–æ–≥—É—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –∞–≤—Ç–æ—Ä—Å–∫–∏–µ –º–µ—Ç–æ–¥–∏–∫–∏ |
| **–ù–µ–¥–æ—Å—Ç–∞—Ç–æ–∫ –Ω–∞—É—á–Ω–æ–π —Å—Ç—Ä–æ–≥–æ—Å—Ç–∏** | –†–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –±–µ–∑ —Å—Å—ã–ª–æ–∫ –Ω–∞ –∏—Å—Ç–æ—á–Ω–∏–∫–∏ –∏ evidence levels | –ù–µ–≤–æ–∑–º–æ–∂–Ω–æ –æ—Ü–µ–Ω–∏—Ç—å –Ω–∞–¥—ë–∂–Ω–æ—Å—Ç—å —Å–æ–≤–µ—Ç–∞ |
| **–û—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç–æ–≤ –¥–ª—è N=1** | –ù–µ—Ç –ø–ª–∞—Ç—Ñ–æ—Ä–º—ã –¥–ª—è –Ω–∞—É—á–Ω–æ–≥–æ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –ø–µ—Ä—Å–æ–Ω–∞–ª—å–Ω—ã—Ö —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–æ–≤ | –ë–∏–æ—Ö–∞–∫–µ—Ä—ã –Ω–µ –º–æ–≥—É—Ç –æ–±—ä–µ–∫—Ç–∏–≤–Ω–æ –æ—Ü–µ–Ω–∏—Ç—å —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –ø—Ä–æ—Ç–æ–∫–æ–ª–æ–≤ |

### Desired State

| –ê—Å–ø–µ–∫—Ç | –ñ–µ–ª–∞–µ–º–æ–µ —Å–æ—Å—Ç–æ—è–Ω–∏–µ |
|--------|-------------------|
| **–î–∞–Ω–Ω—ã–µ** | –í—Å–µ –¥–∞–Ω–Ω—ã–µ –∏–∑ 100+ –∏—Å—Ç–æ—á–Ω–∏–∫–æ–≤ –∞–≥—Ä–µ–≥–∏—Ä—É—é—Ç—Å—è –∞–≤—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–∏ –≤ –µ–¥–∏–Ω—ã–π –¥–∞—à–±–æ—Ä–¥ |
| **AI-—Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏** | 15 —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö AI-–∞–≥–µ–Ω—Ç–æ–≤ –¥–∞—é—Ç –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ —Å —É—á—ë—Ç–æ–º –≤—Å–µ–≥–æ –∫–æ–Ω—Ç–µ–∫—Å—Ç–∞ |
| **–ü–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∞—Ü–∏—è** | –†–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ —É—á–∏—Ç—ã–≤–∞—é—Ç –≥–µ–Ω–µ—Ç–∏–∫—É (SNP), –±–∏–æ–º–∞—Ä–∫–µ—Ä—ã, –∏—Å—Ç–æ—Ä–∏—é —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–æ–≤, —Ü–µ–ª–∏ –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª—è |
| **Custom KB** | –ü–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª—å –º–æ–∂–µ—Ç –∑–∞–≥—Ä—É–∑–∏—Ç—å –ª—é–±—ã–µ –ø—Ä–æ—Ç–æ–∫–æ–ª—ã/–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –∏ AI –±—É–¥–µ—Ç –∏—Ö –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å |
| **–ù–∞—É—á–Ω–∞—è —Å—Ç—Ä–æ–≥–æ—Å—Ç—å** | –ö–∞–∂–¥–∞—è —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è —Å–æ–¥–µ—Ä–∂–∏—Ç —Å—Å—ã–ª–∫–∏ –Ω–∞ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è —Å evidence levels |
| **N=1 —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç—ã** | Biohacker Lab –ø–æ–∑–≤–æ–ª—è–µ—Ç –ø—Ä–æ–≤–æ–¥–∏—Ç—å –Ω–∞—É—á–Ω–æ –æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω—ã–µ –ø–µ—Ä—Å–æ–Ω–∞–ª—å–Ω—ã–µ —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç—ã —Å ML-–∞–Ω–∞–ª–∏–∑–æ–º |

### Gap Analysis

```
–¢–ï–ö–£–©–ï–ï –°–û–°–¢–û–Ø–ù–ò–ï                    GAP                        –¶–ï–õ–ï–í–û–ï –°–û–°–¢–û–Ø–ù–ò–ï
‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ               ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ                       ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ
                                                                
–§—Ä–∞–≥–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ  ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚ñ∂  Integration Platform  ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚ñ∂  –ï–¥–∏–Ω—ã–π –¥–∞—à–±–æ—Ä–¥
(5-10 –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–π)                  (100+ API –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏–π)          (Health Score 0-100)
                                                                
Rule-based —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏   ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚ñ∂  Multi-Agent AI System ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚ñ∂  –ü–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ
(–æ–¥–∏–Ω –∞–ª–≥–æ—Ä–∏—Ç–º)                    (15 —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö          AI-—Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏
                                   –∞–≥–µ–Ω—Ç–æ–≤ + orchestration)       
                                                                
–ù–µ—Ç –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª—å—Å–∫–æ–π KB   ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚ñ∂  Custom RAG Pipeline   ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚ñ∂  –ü–µ—Ä—Å–æ–Ω–∞–ª—å–Ω–∞—è –±–∞–∑–∞
                                   (LlamaIndex + Qdrant)           –∑–Ω–∞–Ω–∏–π –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª—è
                                                                
–ù–µ—Ç –Ω–∞—É—á–Ω–æ–≥–æ N=1          ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚ñ∂  Biohacker Lab Module  ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚ñ∂  ML-powered N=1
                                   (Bayesian A/B, Causal           —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç—ã
                                   Impact)                        
                                                                
–ó–∞–ø–∞–¥–Ω—ã–µ –ø–ª–∞—Ç—Ñ–æ—Ä–º—ã        ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚ñ∂  RU Localization       ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚ñ∂  152-–§–ó compliant
(–Ω–µ—Ç –≤ –†–§)                         (GigaChat, –ª–æ–∫–∞–ª—å–Ω—ã–µ           –ø–ª–∞—Ç—Ñ–æ—Ä–º–∞
                                   –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏–∏)                   
```

---

## Goals & Success Metrics

### Business Goals

| # | Goal | Target (M12) | Target (M24) |
|---|------|--------------|--------------|
| 1 | Monthly Recurring Revenue | 15M ‚ÇΩ | 60M ‚ÇΩ |
| 2 | Paying Users | 10,000 | 40,000 |
| 3 | Free Users | 150,000 | 500,000 |
| 4 | Free ‚Üí Paid Conversion | 5% | 7% |
| 5 | LTV/CAC Ratio | 5x | 7x |

### User Goals

| Persona | Primary Goal | Success Metric |
|---------|--------------|----------------|
| **–ê–ª–µ–∫—Å–µ–π (Advanced Biohacker)** | –û–±—ä–µ–¥–∏–Ω–∏—Ç—å –≤—Å–µ –¥–∞–Ω–Ω—ã–µ –∏ –ø–æ–Ω—è—Ç—å, —á—Ç–æ —Ä–µ–∞–ª—å–Ω–æ —Ä–∞–±–æ—Ç–∞–µ—Ç | –í—Ä–µ–º—è –Ω–∞ –∞–Ω–∞–ª–∏–∑ –¥–∞–Ω–Ω—ã—Ö: -80% (—Å 5—á/–Ω–µ–¥ –¥–æ 1—á/–Ω–µ–¥) |
| **–ú–∞—Ä–∏–Ω–∞ (Health Optimizer)** | –ü–æ–ª—É—á–∏—Ç—å –ø–æ–Ω—è—Ç–Ω—ã–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –±–µ–∑ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –ø–µ—Ä–µ–≥—Ä—É–∑–∞ | Completion rate –ø–ª–∞–Ω–∞ –¥–µ–π—Å—Ç–≤–∏–π: >70% |
| **–î–º–∏—Ç—Ä–∏–π (Longevity Seeker)** | –£–ø—Ä–∞–≤–ª—è—Ç—å –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º –≤–æ–∑—Ä–∞—Å—Ç–æ–º –Ω–∞—É—á–Ω—ã–º –º–µ—Ç–æ–¥–æ–º | –°–Ω–∏–∂–µ–Ω–∏–µ –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –≤–æ–∑—Ä–∞—Å—Ç–∞: -1 –≥–æ–¥ –∑–∞ 12 –º–µ—Å—è—Ü–µ–≤ |

### North Star Metric

> **Monthly Active Users using AI agents for health decisions**

–û–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ "–∞–∫—Ç–∏–≤–Ω–æ–≥–æ –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª—è":
- –ü–æ–ª—É—á–∏–ª ‚â•5 AI-—Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π –∑–∞ –º–µ—Å—è—Ü
- –û—Ç–º–µ—Ç–∏–ª –≤—ã–ø–æ–ª–Ω–µ–Ω–∏–µ ‚â•3 —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π
- –°–∏–Ω—Ö—Ä–æ–Ω–∏–∑–∏—Ä–æ–≤–∞–ª –¥–∞–Ω–Ω—ã–µ —Ö–æ—Ç—è –±—ã —Å 1 –∏—Å—Ç–æ—á–Ω–∏–∫–∞

### Product KPIs

| Category | KPI | Target (M6) | Target (M12) |
|----------|-----|-------------|--------------|
| **Acquisition** | Monthly Signups | 5,000 | 15,000 |
| **Activation** | Users connected ‚â•2 data sources (D7) | 35% | 45% |
| **Engagement** | AI queries per active user per week | 3 | 5 |
| **Retention** | M1 Retention | 45% | 55% |
| **Revenue** | ARPU (paying users) | 1,200 ‚ÇΩ | 1,500 ‚ÇΩ |
| **Satisfaction** | NPS | 40 | 50 |

### Health Outcome KPIs (Long-term)

| KPI | Measurement | Target (M12) |
|-----|-------------|--------------|
| Health Score Improvement | % users with +5 points in 3 months | 60% |
| Successful N=1 Experiments | % completed experiments with significant result | 40% |
| Protocol Adherence | % recommended actions completed | 70% |
| Biological Age Reduction | Average reduction (for Longevity Elite users) | -0.5 years |

---

## User Personas

### Primary Persona 1: –ê–ª–µ–∫—Å–µ–π "Advanced Biohacker"

| Attribute | Value |
|-----------|-------|
| **Age** | 35 –ª–µ—Ç |
| **Location** | –ú–æ—Å–∫–≤–∞ |
| **Profession** | IT-–ø—Ä–µ–¥–ø—Ä–∏–Ω–∏–º–∞—Ç–µ–ª—å |
| **Income** | 800K-1.5M ‚ÇΩ/–º–µ—Å |
| **Devices** | Oura Ring, CGM (Dexcom), WHOOP, iPhone |
| **Monthly Spend (Biohacking)** | $200-500 |

**Goals:**
- –ö–æ–≥–Ω–∏—Ç–∏–≤–Ω–∞—è –æ–ø—Ç–∏–º–∏–∑–∞—Ü–∏—è (–ø—Ä–æ–¥—É–∫—Ç–∏–≤–Ω–æ—Å—Ç—å, —Ñ–æ–∫—É—Å)
- Longevity (—Ü–µ–ª—å: 120+ –ª–µ—Ç)
- Data-driven –±–∏–æ—Ö–∞–∫–∏–Ω–≥ (–ø–æ–Ω—è—Ç—å —á—Ç–æ —Ä–µ–∞–ª—å–Ω–æ —Ä–∞–±–æ—Ç–∞–µ—Ç)

**Pain Points:**
- –î–∞–Ω–Ω—ã–µ —Ä–∞–∑–±—Ä–æ—Å–∞–Ω—ã –ø–æ 7+ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è–º
- 5+ —á–∞—Å–æ–≤/–Ω–µ–¥–µ–ª—é –Ω–∞ —Ä—É—á–Ω—É—é –∞–Ω–∞–ª–∏—Ç–∏–∫—É –≤ Excel
- –ù–µ—Ç –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∞—Ü–∏–∏ –ø–æ–¥ –µ–≥–æ –≥–µ–Ω–µ—Ç–∏–∫—É
- –ù–µ–≤–æ–∑–º–æ–∂–Ω–æ –æ–±—ä–µ–∫—Ç–∏–≤–Ω–æ –æ—Ü–µ–Ω–∏—Ç—å —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –ø—Ä–æ—Ç–æ–∫–æ–ª–æ–≤

**Key Features Wanted:**
- Custom RAG –¥–ª—è –∑–∞–≥—Ä—É–∑–∫–∏ —Å–≤–æ–∏—Ö –ø—Ä–æ—Ç–æ–∫–æ–ª–æ–≤
- –ú—É–ª—å—Ç–∏–∞–≥–µ–Ω—Ç–Ω—ã–π AI —Å –≥–ª—É–±–æ–∫–æ–π –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∞—Ü–∏–µ–π
- N=1 —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç—ã —Å ML-–∞–Ω–∞–ª–∏–∑–æ–º
- –ò–Ω—Ç–µ–≥—Ä–∞—Ü–∏—è —Å–æ –≤—Å–µ–º–∏ –µ–≥–æ —É—Å—Ç—Ä–æ–π—Å—Ç–≤–∞–º–∏

**Willingness to Pay:** 5,000-10,000 ‚ÇΩ/–º–µ—Å

**User Stories:** US-001, US-002, US-003, US-004, US-005, US-006, US-007

---

### Primary Persona 2: –ú–∞—Ä–∏–Ω–∞ "Health Optimizer"

| Attribute | Value |
|-----------|-------|
| **Age** | 42 –≥–æ–¥–∞ |
| **Location** | –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥ |
| **Profession** | –§–∏–Ω–∞–Ω—Å–æ–≤—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä |
| **Income** | 400-600K ‚ÇΩ/–º–µ—Å |
| **Devices** | Apple Watch SE, iPhone |
| **Monthly Spend (Wellness)** | $50-100 |

**Goals:**
- –ë–æ–ª—å—à–µ —ç–Ω–µ—Ä–≥–∏–∏ –¥–ª—è —Ä–∞–±–æ—Ç—ã –∏ –∂–∏–∑–Ω–∏
- –õ—É—á—à–∏–π —Å–æ–Ω (—Å–µ–π—á–∞—Å 6 —á–∞—Å–æ–≤, —Ö–æ—á–µ—Ç 7-8)
- –°–Ω–∏–∂–µ–Ω–∏–µ —Å—Ç—Ä–µ—Å—Å–∞

**Pain Points:**
- –ò–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã–π –ø–µ—Ä–µ–≥—Ä—É–∑ –≤ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–µ
- –ù–µ—Ç –≤—Ä–µ–º–µ–Ω–∏ —Ä–∞–∑–±–∏—Ä–∞—Ç—å—Å—è –≤ –±–∏–æ—Ö–∞–∫–∏–Ω–≥–µ
- –ù–µ –ø–æ–Ω–∏–º–∞–µ—Ç —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –∞–Ω–∞–ª–∏–∑–æ–≤

**Key Features Wanted:**
- –ü—Ä–æ—Å—Ç—ã–µ, –ø–æ–Ω—è—Ç–Ω—ã–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏
- –ù–∞–ø–æ–º–∏–Ω–∞–Ω–∏—è –∏ –º–æ—Ç–∏–≤–∞—Ü–∏—è
- –û–±—ä—è—Å–Ω–µ–Ω–∏–µ –∞–Ω–∞–ª–∏–∑–æ–≤ –ø—Ä–æ—Å—Ç—ã–º —è–∑—ã–∫–æ–º
- AI-–∫–æ—É—á, –∫–æ—Ç–æ—Ä—ã–π –≤–µ–¥—ë—Ç –∑–∞ —Ä—É–∫—É

**Willingness to Pay:** 500-2,000 ‚ÇΩ/–º–µ—Å

**User Stories:** US-008, US-009, US-010, US-011, US-012, US-013, US-014

---

### Primary Persona 3: –î–º–∏—Ç—Ä–∏–π "Longevity Seeker"

| Attribute | Value |
|-----------|-------|
| **Age** | 55 –ª–µ—Ç |
| **Location** | –ö–∞–∑–∞–Ω—å |
| **Profession** | –í—Ä–∞—á-—Ç–µ—Ä–∞–ø–µ–≤—Ç, –∫.–º.–Ω. |
| **Income** | 200-350K ‚ÇΩ/–º–µ—Å |
| **Devices** | Xiaomi Mi Band, Samsung Galaxy |
| **Monthly Spend (Longevity)** | $200-500 |

**Goals:**
- –ó–∞–º–µ–¥–ª–∏—Ç—å —Å—Ç–∞—Ä–µ–Ω–∏–µ (—É–ø—Ä–∞–≤–ª—è—Ç—å pace of aging)
- –û–ø—Ç–∏–º–∏–∑–∏—Ä–æ–≤–∞—Ç—å –±–∏–æ–º–∞—Ä–∫–µ—Ä—ã –¥–æ "–æ–ø—Ç–∏–º–∞–ª—å–Ω—ã—Ö" (–Ω–µ –ø—Ä–æ—Å—Ç–æ "–Ω–æ—Ä–º–∞–ª—å–Ω—ã—Ö")
- Evidence-based —Ä–µ—à–µ–Ω–∏—è (–Ω–∞—É—á–Ω–∞—è —Å—Ç—Ä–æ–≥–æ—Å—Ç—å)

**Pain Points:**
- –ù–µ—Ç –Ω–∞—É—á–Ω–æ–π —Å—Ç—Ä–æ–≥–æ—Å—Ç–∏ –≤ —Å—É—â–µ—Å—Ç–≤—É—é—â–∏—Ö –ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è—Ö
- –ù–µ—Ç –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏–∏ —ç–ø–∏–≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–∏—Ö –¥–∞–Ω–Ω—ã—Ö
- –†–µ—Ñ–µ—Ä–µ–Ω—Å–Ω—ã–µ –∑–Ω–∞—á–µ–Ω–∏—è –≤ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è—Ö –Ω–µ –¥–ª—è longevity

**Key Features Wanted:**
- –°—Å—ã–ª–∫–∏ –Ω–∞ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è (PubMed)
- –û—Ç—Å–ª–µ–∂–∏–≤–∞–Ω–∏–µ –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –≤–æ–∑—Ä–∞—Å—Ç–∞
- –ü–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∞—Ü–∏—è –ø–æ –≥–µ–Ω–µ—Ç–∏–∫–µ
- –†–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –¥–æ–±–∞–≤–∫–∞–º —Å –ø—Ä–æ–≤–µ—Ä–∫–æ–π –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏–π

**Willingness to Pay:** 2,000-5,000 ‚ÇΩ/–º–µ—Å

**User Stories:** US-015, US-016, US-017, US-018, US-019, US-020, US-021

---

## Functional Requirements

### P0 ‚Äî Must Have (MVP)

| ID | Requirement | User Stories | Agents |
|----|-------------|--------------|--------|
| **FR-001** | –¶–µ–Ω—Ç—Ä–∞–ª–∏–∑–æ–≤–∞–Ω–Ω—ã–π –¥–∞—à–±–æ—Ä–¥ —Å Health Score | US-001 | Integration Agent, Data Scientist Agent |
| **FR-002** | –ò–Ω—Ç–µ–≥—Ä–∞—Ü–∏—è —Å Oura Ring (sleep, HRV) | US-001, US-005 | Integration Agent, Sleep Agent |
| **FR-003** | –ò–Ω—Ç–µ–≥—Ä–∞—Ü–∏—è —Å Apple Watch (HealthKit) | US-008, US-012 | Integration Agent |
| **FR-004** | –ó–∞–≥—Ä—É–∑–∫–∞ –∏ –æ–±—Ä–∞–±–æ—Ç–∫–∞ PDF –∞–Ω–∞–ª–∏–∑–æ–≤ –∫—Ä–æ–≤–∏ (INVITRO) | US-001, US-011 | Lab Interpreter Agent |
| **FR-005** | Custom RAG: –∑–∞–≥—Ä—É–∑–∫–∞ –ø—Ä–æ—Ç–æ–∫–æ–ª–æ–≤ (PDF/MD) | US-002 | Custom Protocol Agent |
| **FR-006** | –ü–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –æ—Ç AI-–∞–≥–µ–Ω—Ç–æ–≤ | US-004, US-009, US-018 | –í—Å–µ –∞–≥–µ–Ω—Ç—ã |
| **FR-007** | Telegram Bot –∏–Ω—Ç–µ—Ä—Ñ–µ–π—Å | US-006, US-010 | Orchestrator Agent |
| **FR-008** | Safety Module: –ø—Ä–æ–≤–µ—Ä–∫–∞ –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏–π | US-004, US-020 | Safety Agent |
| **FR-009** | –ò–Ω—Ç–µ–≥—Ä–∞—Ü–∏—è —Å 23andMe (raw data) | US-004, US-018 | Genomics Agent |
| **FR-010** | –ï–∂–µ–Ω–µ–¥–µ–ª—å–Ω—ã–µ –æ—Ç—á—ë—Ç—ã —Å –∏–Ω—Å–∞–π—Ç–∞–º–∏ | US-007, US-014 | Coach Agent, Data Scientist Agent |
| **FR-011** | –ò–Ω—Ç–µ—Ä–ø—Ä–µ—Ç–∞—Ü–∏—è –∞–Ω–∞–ª–∏–∑–æ–≤ –∫—Ä–æ–≤–∏ –ø—Ä–æ—Å—Ç—ã–º —è–∑—ã–∫–æ–º | US-011 | Lab Interpreter Agent |
| **FR-012** | –†–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ —É–ª—É—á—à–µ–Ω–∏—é —Å–Ω–∞ | US-012 | Sleep Agent, Coach Agent |
| **FR-013** | –ü–æ–Ω—è—Ç–Ω—ã–π –ø–ª–∞–Ω –¥–µ–π—Å—Ç–≤–∏–π "—Å —á–µ–≥–æ –Ω–∞—á–∞—Ç—å" | US-009 | Coach Agent |
| **FR-014** | –ù–∞–ø–æ–º–∏–Ω–∞–Ω–∏—è —á–µ—Ä–µ–∑ Telegram | US-010 | Coach Agent |
| **FR-015** | –ó–∞–≥—Ä—É–∑–∫–∞ —ç–ø–∏–≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–∏—Ö —Ç–µ—Å—Ç–æ–≤ (TruDiagnostic) | US-015 | Longevity Agent |
| **FR-016** | –û—Ç—Å–ª–µ–∂–∏–≤–∞–Ω–∏–µ –±–∏–æ–º–∞—Ä–∫–µ—Ä–æ–≤ –¥–æ–ª–≥–æ–ª–µ—Ç–∏—è | US-016 | Longevity Agent, Lab Interpreter Agent |
| **FR-017** | –ü–æ–∏—Å–∫ –Ω–∞—É—á–Ω—ã—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π (PubMed) | US-017 | Research Agent |
| **FR-018** | –ü–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –ø—Ä–æ—Ç–æ–∫–æ–ª—ã –¥–æ–ª–≥–æ–ª–µ—Ç–∏—è | US-018 | Longevity Agent, Genomics Agent |

### P1 ‚Äî Should Have

| ID | Requirement | User Stories | Agents |
|----|-------------|--------------|--------|
| **FR-019** | –û—Ç—Å–ª–µ–∂–∏–≤–∞–Ω–∏–µ —ç—Ñ—Ñ–µ–∫—Ç–æ–≤ –¥–æ–±–∞–≤–æ–∫ –Ω–∞ –±–∏–æ–º–∞—Ä–∫–µ—Ä—ã | US-003 | Data Scientist Agent, Nutrition Agent |
| **FR-020** | N=1 —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç—ã (Biohacker Lab) | US-005 | Coach Agent, Data Scientist Agent |
| **FR-021** | –¢–µ—Ö–Ω–∏–∫–∏ —Å–Ω–∏–∂–µ–Ω–∏—è —Å—Ç—Ä–µ—Å—Å–∞ —Å –æ—Ç—Å–ª–µ–∂–∏–≤–∞–Ω–∏–µ–º | US-013 | Mental Health Agent |
| **FR-022** | –û—Ç—Å–ª–µ–∂–∏–≤–∞–Ω–∏–µ –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –≤–æ–∑—Ä–∞—Å—Ç–∞ –≤–æ –≤—Ä–µ–º–µ–Ω–∏ | US-019 | Longevity Agent, Data Scientist Agent |
| **FR-023** | –ü—Ä–æ–≤–µ—Ä–∫–∞ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏–π –¥–æ–±–∞–≤–æ–∫ | US-020 | Safety Agent |
| **FR-024** | –ö–≤–∞—Ä—Ç–∞–ª—å–Ω—ã–π –æ—Ç—á—ë—Ç –æ –ø—Ä–æ–≥—Ä–µ—Å—Å–µ | US-021 | Longevity Agent, Coach Agent |
| **FR-025** | –ò–Ω—Ç–µ–≥—Ä–∞—Ü–∏—è —Å CGM (Dexcom/Libre) | US-001 | Integration Agent |
| **FR-026** | Telegram WebApp –∏–Ω—Ç–µ—Ä—Ñ–µ–π—Å | US-006 | ‚Äî |
| **FR-027** | Multi-agent conversation (–º–∞—Ä—à—Ä—É—Ç–∏–∑–∞—Ü–∏—è –≤–æ–ø—Ä–æ—Å–æ–≤) | US-006 | Orchestrator Agent |

### P2 ‚Äî Nice to Have

| ID | Requirement | Description | Priority Reason |
|----|-------------|-------------|-----------------|
| **FR-028** | Digital Twin (—Å–∏–º—É–ª—è—Ü–∏–∏) | –ü—Ä–æ–≥–Ω–æ–∑–∏—Ä–æ–≤–∞–Ω–∏–µ "—á—Ç–æ –±—É–¥–µ—Ç —á–µ—Ä–µ–∑ 5 –ª–µ—Ç" | –¢—Ä–µ–±—É–µ—Ç –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω—ã—Ö ML-—Ä–µ—Å—É—Ä—Å–æ–≤ |
| **FR-029** | Voice –∏–Ω—Ç–µ—Ä—Ñ–µ–π—Å (–ê–ª–∏—Å–∞) | –ì–æ–ª–æ—Å–æ–≤–æ–µ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏–µ | –î–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–π –∫–∞–Ω–∞–ª, –Ω–µ –∫—Ä–∏—Ç–∏—á–µ–Ω –¥–ª—è MVP |
| **FR-030** | Mobile App (Flutter) | –ù–∞—Ç–∏–≤–Ω–æ–µ –º–æ–±–∏–ª—å–Ω–æ–µ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–µ | Telegram-first —Å—Ç—Ä–∞—Ç–µ–≥–∏—è –¥–ª—è MVP |
| **FR-031** | Community shared protocols | –ú–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å –ø—Ä–æ—Ç–æ–∫–æ–ª–æ–≤ | –¢—Ä–µ–±—É–µ—Ç –∫—Ä–∏—Ç–∏—á–µ—Å–∫–æ–π –º–∞—Å—Å—ã –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–µ–π |
| **FR-032** | B2B Corporate Wellness dashboard | –ê–¥–º–∏–Ω-–ø–∞–Ω–µ–ª—å –¥–ª—è HR | Post-MVP —Å–µ–≥–º–µ–Ω—Ç |

---

## Non-Functional Requirements

### Performance

| Requirement | Target | Priority |
|-------------|--------|----------|
| AI Agent response time | < 5 seconds (p95) | P0 |
| Dashboard load time | < 2 seconds | P0 |
| Data sync latency (wearables) | < 15 minutes | P1 |
| RAG retrieval time | < 1 second | P0 |
| Concurrent users support | 10,000 | P1 |

### Availability & Reliability

| Requirement | Target | Priority |
|-------------|--------|----------|
| System uptime | 99.5% | P0 |
| Planned maintenance window | < 2 hours/month | P1 |
| Data backup frequency | Daily | P0 |
| Recovery Point Objective (RPO) | < 24 hours | P0 |
| Recovery Time Objective (RTO) | < 4 hours | P1 |

### Security & Compliance

| Requirement | Target | Priority |
|-------------|--------|----------|
| **152-–§–ó Compliance** | Full compliance | P0 (Critical) |
| Data encryption at rest | AES-256 | P0 |
| Data encryption in transit | TLS 1.3 | P0 |
| User data residency | Russia only | P0 |
| Authentication | OAuth 2.0 + 2FA | P0 |
| Audit logging | All data access | P0 |
| GDPR-like user rights | Export/delete data | P0 |

### Scalability

| Requirement | Target | Priority |
|-------------|--------|----------|
| Users (M12) | 150,000 | P1 |
| Users (M24) | 500,000 | P1 |
| Data storage per user | 5 GB (avg) | P1 |
| RAG documents per user | 100 (avg) | P1 |
| API integrations | 100+ | P1 |

### Usability

| Requirement | Target | Priority |
|-------------|--------|----------|
| Language | Russian (primary) | P0 |
| Onboarding completion | > 70% | P0 |
| Time to first value (first insight) | < 10 minutes | P0 |
| Mobile-friendly (Telegram WebApp) | Full support | P0 |
| Accessibility (WCAG) | Level A | P2 |

---

## Constraints

### Technical Constraints

| Constraint | Description | Impact |
|------------|-------------|--------|
| **152-–§–ó** | –í—Å–µ –ø–µ—Ä—Å–æ–Ω–∞–ª—å–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ –¥–æ–ª–∂–Ω—ã —Ö—Ä–∞–Ω–∏—Ç—å—Å—è –≤ –†–§ | –í—ã–±–æ—Ä —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö cloud-–ø—Ä–æ–≤–∞–π–¥–µ—Ä–æ–≤ (Yandex Cloud, VK Cloud) |
| **LLM Latency** | –û—Ç–≤–µ—Ç AI-–∞–≥–µ–Ω—Ç–∞ –¥–æ–ª–∂–µ–Ω –±—ã—Ç—å < 5 —Å–µ–∫—É–Ω–¥ | –û–ø—Ç–∏–º–∏–∑–∞—Ü–∏—è –ø—Ä–æ–º–ø—Ç–æ–≤, –∫—ç—à–∏—Ä–æ–≤–∞–Ω–∏–µ, streaming |
| **API Rate Limits** | Wearables APIs –∏–º–µ—é—Ç –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è –Ω–∞ –∑–∞–ø—Ä–æ—Å—ã | –ö—ç—à–∏—Ä–æ–≤–∞–Ω–∏–µ –¥–∞–Ω–Ω—ã—Ö, batching –∑–∞–ø—Ä–æ—Å–æ–≤ |
| **Telegram Bot Limits** | –û–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è –Ω–∞ —Ä–∞–∑–º–µ—Ä —Å–æ–æ–±—â–µ–Ω–∏–π –∏ —Ñ–∞–π–ª–æ–≤ | –ê–¥–∞–ø—Ç–∞—Ü–∏—è UI –ø–æ–¥ Telegram —Ñ–æ—Ä–º–∞—Ç |
| **LLM Context Window** | –û–≥—Ä–∞–Ω–∏—á–µ–Ω–∏–µ –∫–æ–Ω—Ç–µ–∫—Å—Ç–∞ GigaChat/YandexGPT | RAG –¥–ª—è long-term memory, summarization |

### Business Constraints

| Constraint | Description | Impact |
|------------|-------------|--------|
| **Wellness ‚â† Medicine** | –ù–ï —Å—Ç–∞–≤–∏–º –¥–∏–∞–≥–Ω–æ–∑—ã, –ù–ï –∑–∞–º–µ–Ω—è–µ–º –≤—Ä–∞—á–∞ | –û–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–µ –¥–∏—Å–∫–ª–µ–π–º–µ—Ä—ã, Safety Agent |
| **Budget MVP** | –û–≥—Ä–∞–Ω–∏—á–µ–Ω–Ω—ã–π runway | Telegram-first –≤–º–µ—Å—Ç–æ native apps |
| **Team Size** | –°—Ç–∞—Ä—Ç–æ–≤–∞—è –∫–æ–º–∞–Ω–¥–∞ 5-10 —á–µ–ª–æ–≤–µ–∫ | –ü—Ä–∏–æ—Ä–∏—Ç–∏–∑–∞—Ü–∏—è P0 —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π |
| **Time-to-Market** | MVP –∑–∞ 6 –º–µ—Å—è—Ü–µ–≤ | –§–æ–∫—É—Å –Ω–∞ core features |

### Regulatory Constraints

| Constraint | Description | Mitigation |
|------------|-------------|------------|
| –ó–∞–ø—Ä–µ—Ç –Ω–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –¥–∏–∞–≥–Ω–æ–∑—ã | –ë–µ–∑ –ª–∏—Ü–µ–Ω–∑–∏–∏ –Ω–µ–ª—å–∑—è —Å—Ç–∞–≤–∏—Ç—å –¥–∏–∞–≥–Ω–æ–∑—ã | Wellness positioning, –¥–∏—Å–∫–ª–µ–π–º–µ—Ä—ã |
| –†–µ–∫–ª–∞–º–Ω—ã–µ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è | –û–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è –Ω–∞ —Ä–µ–∫–ª–∞–º—É –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É—Å–ª—É–≥ | –Æ—Ä–∏–¥–∏—á–µ—Å–∫–∞—è —ç–∫—Å–ø–µ—Ä—Ç–∏–∑–∞ –∫–æ–Ω—Ç–µ–Ω—Ç–∞ |
| –ü–µ—Ä—Å–æ–Ω–∞–ª—å–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ | 152-–§–ó —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è | Data residency –≤ –†–§, —Å–æ–≥–ª–∞—Å–∏—è |

### Ethical Constraints

| Constraint | Description |
|------------|-------------|
| No dangerous protocols | –ù–µ —Ä–µ–∫–æ–º–µ–Ω–¥—É–µ–º –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–æ –æ–ø–∞—Å–Ω—ã–µ –∏–Ω—Ç–µ—Ä–≤–µ–Ω—Ü–∏–∏ |
| No children | –ù–µ —Ä–∞–±–æ—Ç–∞–µ–º —Å –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª—è–º–∏ –º–ª–∞–¥—à–µ 18 –ª–µ—Ç |
| Pregnancy/nursing | –¢—Ä–µ–±—É–µ–º –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–∏ —Å –≤—Ä–∞—á–æ–º |
| Mental health | Red flags detection –¥–ª—è –∫—Ä–∏—Ç–∏—á–µ—Å–∫–∏—Ö —Å–æ—Å—Ç–æ—è–Ω–∏–π |

---

## Assumptions

### Validated Assumptions ‚úÖ

| Assumption | Evidence | Confidence |
|------------|----------|------------|
| –ë–∏–æ—Ö–∞–∫–µ—Ä—ã –≥–æ—Ç–æ–≤—ã –ø–ª–∞—Ç–∏—Ç—å 2,000-10,000 ‚ÇΩ/–º–µ—Å –∑–∞ —Ü–µ–Ω–Ω–æ–µ —Ä–µ—à–µ–Ω–∏–µ | Competitive analysis (InsideTracker $149-340+, Wild Health $362-495) | High |
| Telegram ‚Äî –æ—Å–Ω–æ–≤–Ω–æ–π –∫–∞–Ω–∞–ª –¥–ª—è —Ü–µ–ª–µ–≤–æ–π –∞—É–¥–∏—Ç–æ—Ä–∏–∏ –≤ –†–§ | User research, market data | High |
| 152-–§–ó –Ω–µ –±–ª–æ–∫–∏—Ä—É–µ—Ç wellness-–ø—Ä–æ–¥—É–∫—Ç—ã | –Æ—Ä–∏–¥–∏—á–µ—Å–∫–∞—è —ç–∫—Å–ø–µ—Ä—Ç–∏–∑–∞ | High |
| –î–∞–Ω–Ω—ã–µ —Ä–∞–∑–±—Ä–æ—Å–∞–Ω—ã –ø–æ 5+ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è–º —É –ø—Ä–æ–¥–≤–∏–Ω—É—Ç—ã—Ö –±–∏–æ—Ö–∞–∫–µ—Ä–æ–≤ | User interviews (n=15) | High |

### Assumptions to Validate üîÑ

| Assumption | Validation Method | Risk if Wrong |
|------------|-------------------|---------------|
| Telegram Bot –¥–æ—Å—Ç–∞—Ç–æ—á–µ–Ω –∫–∞–∫ MVP interface | Beta test M1-M3 | Pivot to mobile-first |
| Custom RAG –¥–∞—ë—Ç –∑–Ω–∞—á–∏–º–æ–µ —É–ª—É—á—à–µ–Ω–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π | A/B test M2-M3 | Deprioritize feature |
| –ü–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–∏ –±—É–¥—É—Ç –∑–∞–≥—Ä—É–∂–∞—Ç—å —Å–≤–æ–∏ –ø—Ä–æ—Ç–æ–∫–æ–ª—ã | Usage analytics M1-M3 | Simplify KB approach |
| GigaChat –¥–æ—Å—Ç–∞—Ç–æ—á–µ–Ω –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –∫–æ–Ω—Ç–µ–∫—Å—Ç–∞ | Quality evaluation M1 | Add GPT-4o fallback |
| –ü–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–∏ –≥–æ—Ç–æ–≤—ã –ø–æ–¥–∫–ª—é—á–∞—Ç—å 3+ –∏—Å—Ç–æ—á–Ω–∏–∫–∞ –¥–∞–Ω–Ω—ã—Ö | Activation metrics M1-M3 | Simplify onboarding |

---

## Out of Scope

### Out of Scope for MVP (M1-M6)

| Feature | Reason | Future Phase |
|---------|--------|--------------|
| Native Mobile App (Flutter) | Telegram-first —Å—Ç—Ä–∞—Ç–µ–≥–∏—è | Phase 2 (M6-M12) |
| Voice Interface (–ê–ª–∏—Å–∞) | –ù–µ –∫—Ä–∏—Ç–∏—á–Ω–æ –¥–ª—è core value | Phase 3 (M12+) |
| Digital Twin simulations | –¢—Ä–µ–±—É–µ—Ç –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω—ã—Ö ML-—Ä–µ—Å—É—Ä—Å–æ–≤ | Phase 3 (M12+) |
| B2B/Enterprise features | –§–æ–∫—É—Å –Ω–∞ B2C –¥–ª—è PMF | Phase 3 (M12+) |
| Community/Marketplace | –¢—Ä–µ–±—É–µ—Ç –∫—Ä–∏—Ç–∏—á–µ—Å–∫–æ–π –º–∞—Å—Å—ã | Phase 3 (M12+) |
| International markets | –§–æ–∫—É—Å –Ω–∞ –†–§ –¥–ª—è MVP | Phase 4 (M24+) |

### Explicit Non-Goals

| Non-Goal | Reason |
|----------|--------|
| Medical diagnosis | –†–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã–µ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è, wellness ‚â† medicine |
| Prescription recommendations | –¢—Ä–µ–±—É–µ—Ç –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ª–∏—Ü–µ–Ω–∑–∏–∏ |
| Children (<18) support | –≠—Ç–∏—á–µ—Å–∫–∏–µ –∏ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã–µ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è |
| Emergency health situations | –ù–µ –∑–∞–º–µ–Ω—è–µ–º —Å–∫–æ—Ä—É—é –ø–æ–º–æ—â—å |

---

## Dependencies

### External Dependencies

| Dependency | Type | Owner/Provider | Status | Risk |
|------------|------|----------------|--------|------|
| **Oura Ring API** | Integration | Oura Health | Available | Medium (rate limits) |
| **Apple HealthKit** | Integration | Apple | Available | Low |
| **INVITRO API** | Integration | INVITRO | To negotiate | High (no public API) |
| **23andMe raw data** | Data format | 23andMe | Available | Low |
| **GigaChat API** | LLM | Sber | Available | Medium (quality) |
| **YandexGPT API** | LLM (fallback) | Yandex | Available | Low |
| **DrugBank API** | Safety data | DrugBank | Available (paid) | Low |
| **PubMed API** | Research | NCBI | Available (free) | Low |
| **Telegram Bot API** | Platform | Telegram | Available | Low |
| **Yandex Cloud** | Infrastructure | Yandex | Available | Low |

### Internal Dependencies

| Dependency | Type | Owner | Status |
|------------|------|-------|--------|
| RAG Pipeline (LlamaIndex + Qdrant) | Technical | AI Team | In development |
| Multi-agent orchestration (LangGraph) | Technical | AI Team | In development |
| User authentication system | Technical | Backend Team | In development |
| Data ingestion pipeline | Technical | Backend Team | In development |

### Cross-Team Dependencies

| Dependency | From Team | To Team | Description |
|------------|-----------|---------|-------------|
| API contracts | Backend | Mobile/Telegram | API schema for integrations |
| Agent prompts | Product | AI | Prompt engineering for each agent |
| Safety rules | Legal | AI | Rules for Safety Agent |
| Content guidelines | Legal | Content | Disclaimer templates |

---

## Risks & Mitigations

### High Priority Risks

| Risk | Probability | Impact | Mitigation | Owner |
|------|-------------|--------|------------|-------|
| **–†–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã–µ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è** | High | High | Wellness positioning, –¥–∏—Å–∫–ª–µ–π–º–µ—Ä—ã –≤–µ–∑–¥–µ, Safety Agent, —é—Ä–∏–¥–∏—á–µ—Å–∫–∞—è —ç–∫—Å–ø–µ—Ä—Ç–∏–∑–∞ –≤—Å–µ–≥–æ –∫–æ–Ω—Ç–µ–Ω—Ç–∞ | Legal + Product |
| **AI –≥–∞–ª–ª—é—Ü–∏–Ω–∞—Ü–∏–∏ –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–º –∫–æ–Ω—Ç–µ–∫—Å—Ç–µ** | Medium | Critical | RAG —Å –Ω–∞—É—á–Ω—ã–º–∏ –±–∞–∑–∞–º–∏, Safety Agent —Å hard blocks, human-in-the-loop –¥–ª—è –∫—Ä–∏—Ç–∏—á–Ω—ã—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π, source attribution | AI Team |
| **–ù–∏–∑–∫–∞—è –∫–æ–Ω–≤–µ—Ä—Å–∏—è Free ‚Üí Paid** | High | High | Value demonstration, trial periods, gamification, personalized upsell triggers | Product + Growth |
| **–ö–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏—è BigTech (Apple, Google)** | High | High | –§–æ–∫—É—Å –Ω–∞ advanced biohackers (–Ω–µ mass market), –≥–ª—É–±–æ–∫–∞—è –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∞—Ü–∏—è —á–µ—Ä–µ–∑ Custom RAG, RU —Ä—ã–Ω–æ–∫ | Product |

### Medium Priority Risks

| Risk | Probability | Impact | Mitigation | Owner |
|------|-------------|--------|------------|-------|
| **API dependency (wearables)** | Medium | Medium | Multi-vendor strategy, data caching, offline mode | Backend |
| **GigaChat quality issues** | Medium | Medium | Fallback to YandexGPT, GPT-4o for critical flows | AI Team |
| **INVITRO API unavailable** | High | Medium | PDF parser as fallback, manual upload support | Backend |
| **User privacy concerns** | Medium | Medium | Transparent data policy, user control, encryption | Security + Legal |

### Low Priority Risks

| Risk | Probability | Impact | Mitigation | Owner |
|------|-------------|--------|------------|-------|
| **Data breach** | Low | Critical | E2E encryption, 152-–§–ó compliance, SOC2 prep, security audits | Security |
| **Team scaling challenges** | Medium | Low | Documentation, processes, mentorship | HR + CTO |
| **LLM cost overruns** | Medium | Low | Caching, query optimization, tier-based limits | AI Team + Finance |

---

## Timeline & Milestones

### Phase 1: MVP (M1-M6)

| Milestone | Target Date | Deliverables | Success Criteria |
|-----------|-------------|--------------|------------------|
| **M1: Core Infrastructure** | Month 1 | Auth, Database, Telegram Bot skeleton | System online |
| **M2: First Integrations** | Month 2 | Oura + Apple Watch + PDF parser | 3 data sources working |
| **M3: First Agents** | Month 3 | Coach Agent + Sleep Agent + Lab Interpreter | Basic recommendations working |
| **M4: Custom RAG** | Month 4 | Protocol upload + RAG pipeline | User can upload and query |
| **M5: All P0 Agents** | Month 5 | 15 agents + orchestration | Full agent coverage |
| **M6: MVP Launch** | Month 6 | Beta launch, onboarding, payments | 1,000 beta users |

### Phase 2: Growth (M6-M12)

| Milestone | Target Date | Deliverables | Success Criteria |
|-----------|-------------|--------------|------------------|
| **M7-M8** | Month 7-8 | Telegram WebApp, more integrations | 5,000 users |
| **M9-M10** | Month 9-10 | N=1 Biohacker Lab, advanced analytics | 10,000 users |
| **M11-M12** | Month 11-12 | Full tier structure, referral program | 50,000 users, 5,000 paying |

### Phase 3: Scale (M12-M24)

| Milestone | Target Date | Deliverables | Success Criteria |
|-----------|-------------|--------------|------------------|
| **M13-M18** | Month 13-18 | Mobile App (Flutter), B2B features | 200,000 users |
| **M19-M24** | Month 19-24 | Marketplace, international prep | 500,000 users, 40,000 paying |

---

## Appendix

### A. AI Agents Overview

| Agent | Responsibility | Priority |
|-------|---------------|----------|
| **Orchestrator Agent** | –ö–æ–æ—Ä–¥–∏–Ω–∞—Ü–∏—è –∞–≥–µ–Ω—Ç–æ–≤, –º–∞—Ä—à—Ä—É—Ç–∏–∑–∞—Ü–∏—è –∑–∞–ø—Ä–æ—Å–æ–≤ | P0 |
| **Coach Agent** | –ú–æ—Ç–∏–≤–∞—Ü–∏—è, –ø—Ä–∏–≤—ã—á–∫–∏, –ø–ª–∞–Ω—ã –¥–µ–π—Å—Ç–≤–∏–π | P0 |
| **Sleep Agent** | –ê—Ä—Ö–∏—Ç–µ–∫—Ç—É—Ä–∞ —Å–Ω–∞, —Ü–∏—Ä–∫–∞–¥–Ω—ã–µ —Ä–∏—Ç–º—ã | P0 |
| **Nutrition Agent** | –ù—É—Ç—Ä–∏–≥–µ–Ω–æ–º–∏–∫–∞, –¥–∏–µ—Ç—ã | P0 |
| **Lab Interpreter Agent** | –ò–Ω—Ç–µ—Ä–ø—Ä–µ—Ç–∞—Ü–∏—è –∞–Ω–∞–ª–∏–∑–æ–≤ –∫—Ä–æ–≤–∏ | P0 |
| **Genomics Agent** | –î–ù–ö-–∞–Ω–∞–ª–∏–∑, SNP –∏–Ω—Ç–µ—Ä–ø—Ä–µ—Ç–∞—Ü–∏—è | P0 |
| **Longevity Agent** | –ê–Ω—Ç–∏—Å—Ç–∞—Ä–µ–Ω–∏–µ, –±–∏–æ–≤–æ–∑—Ä–∞—Å—Ç | P0 |
| **Safety Agent** | –ü—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è, –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è | P0 |
| **Integration Agent** | –°–∏–Ω—Ç–µ–∑ –¥–∞–Ω–Ω—ã—Ö –∏–∑ –≤—Å–µ—Ö –∏—Å—Ç–æ—á–Ω–∏–∫–æ–≤ | P0 |
| **Data Scientist Agent** | –ê–Ω–∞–ª–∏–∑ –ø–∞—Ç—Ç–µ—Ä–Ω–æ–≤, –∫–æ—Ä—Ä–µ–ª—è—Ü–∏–∏ | P0 |
| **Research Agent** | –ü–æ–∏—Å–∫ –Ω–∞—É—á–Ω—ã—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π | P0 |
| **Custom Protocol Agent** | –ü–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª—å—Å–∫–∏–µ –º–µ—Ç–æ–¥–∏–∫–∏ | P0 |
| **Mental Health Agent** | –°—Ç—Ä–µ—Å—Å, —Ç—Ä–µ–≤–æ–∂–Ω–æ—Å—Ç—å | P1 |
| **Cognitive Agent** | –ù–æ–æ—Ç—Ä–æ–ø—ã, –Ω–µ–π—Ä–æ—Ñ–∏–¥–±—ç–∫ | P1 |
| **Fitness Agent** | –¢—Ä–µ–Ω–∏—Ä–æ–≤–∫–∏, –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ | P1 |

### B. Integrations Roadmap (MVP)

| Category | Integration | Priority | API Status |
|----------|-------------|----------|------------|
| **Wearables** | Oura Ring | P0 | Available |
| **Wearables** | Apple Watch (HealthKit) | P0 | Available |
| **Labs (RU)** | INVITRO (PDF parser) | P0 | PDF fallback |
| **Genomics** | 23andMe (raw data) | P0 | Available |
| **Fitness** | Strava | P1 | Available |
| **CGM** | Dexcom G7 | P1 | Available |
| **Nutrition** | MyFitnessPal | P1 | Available |
| **Epigenetics** | TruDiagnostic (PDF) | P0 | PDF only |

### C. References

- Project Brief: `context/project-brief.yaml`
- Vision: `docs/discovery/vision.md`
- User Stories: `docs/discovery/user-stories.md`
- Personas: `docs/discovery/personas.md`
- Business Model: `docs/business/business-model.md`
- Competitive Analysis: `docs/discovery/competitive-analysis.md`
- Technical Architecture: `docs/discovery/technical/langraph-architecture.md`

---

*–î–æ–∫—É–º–µ–Ω—Ç —Å–æ–∑–¥–∞–Ω: 2026-01-26*  
*Product Agent v1.0*
